General Information |
| Summary |
The purpose of this study was to determine the safety and therapeutic effect of sub-retinal transplantation of human embryo stem cell derived retinal pigment epitheliums (hESC-RPE) in patients with macular degeneration diseases, and explore new treatment modalities for macular degeneration diseases (Age-related macular degeneration and Stargardt's macular dystrophy). |
| Clinical trials phase |
Phases 1/2 |
| Start date (estimated) |
2015-05-01 |
| End date (estimated) |
2019-12-31 |
| Clinical feature |
| Label |
macular degeneration |
| Link |
http://purl.obolibrary.org/obo/DOID_4448 |
| Description |
A retinal degeneration characterized by gradual deterioration of light-sensing cells in the tissues at the back of the eye and has_symptom vision loss.; Xref MGI. |
|
| Publications |
|
Administrative Information |
| NCT number |
NCT02749734 |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-OCB-15006423 |
| Other study identifiers |
| Name |
ChiCTR-OCB-15006423 |
| Description |
Chinese Clinical Trial Registry (ChiCTR) |
|
| Source weblink |
https://clinicaltrials.gov/ct2/show/NCT02749734 |
| Public contact |
| Email |
qinzyin@aliyun.com |
| Public email |
qinzyin@aliyun.com |
| First name |
Zhengqin |
| Last name |
Yin |
| Phone |
+86 023 68754401 |
| Country |
|
|
| Sponsors |
Chinese Academy of Sciences
Southwest Hospital, China
|
Cells |
| Source pluripotent stem cell lines |
|
| Which differentiated cell type is used |
| Label |
retinal pigment epithelial cell |
| Link |
http://purl.obolibrary.org/obo/CL_0002586 |
| Description |
An epithelial cell of the retinal pigmented epithelium. |
|
Recruitment |
| Recruitment Status |
Active, not recruiting |
| Comment recruitment status |
Estimated number of participants according to Chinese Clinical Trial Registry (ChiCTR): 10; Estimated number of participants according to clinicaltrials.gov: 15. |
| Estimated number of participants |
9 |
| Contact institutions/departments |
|
